The DZIF Academy is pleased to open the call for application for the third DZIF Prize for Translational Infection Research. The German Center for Infection Research (DZIF) will award a prize of 5.000
DZIF scientists at the Heidelberg University Hospital developed a virus blocker against hepatitis B and D, which has been successful in two clinical trials
There are four globally endemic human coronaviruses which, together with the better known rhinoviruses, are responsible for causing common colds. Usually, infections with these viruses are harmless to
According to National Reference Center for Surveillance of Nosocomial Infections estimates, up to 15,000 patients die of hospital-acquired infections in Germany every year. Here, multidrug-resistant
DZIF researchers have discovered that a protein which is well known for its role as a tumor suppressor is also required for inhibition of the replication of the coronavirus that causes SARS. The
The communities of microbes in the intestine of the mouse, the gut microbiota, have a significant impact on the research output. However, there is still insufficient information available about many
DZIF scientists at the University of Tübingen have now uncovered a major cause of blood poisoning by staphylococci infections. The results of their study have been published in the latest issue of
Since the start of the HIV epidemic, there have been speculations as to why HIV and the immunodeficiency syndrome it causes have spread so much more in Africa than in other countries around the world
In a clinical trial at the German Center for Infection Research (DZIF), leukaemia patients are being administered specially purified immune cells, so-called memory T cells, for the first time after a
Today’s World Hepatitis Day sets an ambitious goal: to eliminate viral hepatitis, especially hepatitis B and C, from the planet by 2030. Germany has also joined this international campaign. Scientists
